Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Neuroprotective activity described for CoCensys neurosteroid

Feb. 4, 1998

Neuroprotective effects of IL-1ra

Feb. 4, 1998

New targets for stroke: neurotrophic growth factors

Feb. 4, 1998

Phase III trial compares immediate and delayed treatment with fomivirsen for CMV retinitis

Feb. 4, 1998

Promising efficacy reported at AIDS conference for amprenavir combinations

Feb. 3, 1998

Potent antiretroviral activity shown for abacavir + protease inhibitor in HIV-positive patients

Feb. 3, 1998

Glutamate antagonists: a new frontier in stroke research

Feb. 2, 1998

Antithrombotic agents in stroke indications

Feb. 2, 1998

HMR's new ketolides extensively discussed at conference this week

Jan. 23, 1998

Abbott presents in vitro and in vivo efficacy data on tricyclic ketolides

Jan. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.